Azacitidine or intensive chemotherapy for older patients with secondary or therapy-related acute myeloid leukemia

The treatment of older patients with acute myeloid leukemia that is secondary to previous myelodysplastic syndrome, myeloproliferative neoplasm, or prior cytotoxic exposure remains unsatisfactory. We compared 92 and 107 patients treated, respectively, with intensive chemotherapy or azacitidine withi...

Descripción completa

Detalles Bibliográficos
Autores principales: Dumas, Pierre-Yves, Bertoli, Sarah, Bérard, Emilie, Médiavilla, Clémence, Yon, Edwige, Tavitian, Suzanne, Leguay, Thibaut, Huguet, Françoise, Forcade, Edouard, Milpied, Noël, Sarry, Audrey, Sauvezie, Mathieu, Bories, Pierre, Pigneux, Arnaud, Récher, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668025/
https://www.ncbi.nlm.nih.gov/pubmed/29108292
http://dx.doi.org/10.18632/oncotarget.15988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668025/
https://www.ncbi.nlm.nih.gov/pubmed/29108292
http://dx.doi.org/10.18632/oncotarget.15988

Ejemplares similares